Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-06-02

FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mirena (levonorgestrel) from Bayer HealthCare Pharmaceuticals Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirena (levonorgestrel-releasing intrauterine system)

Snippet

SUPPL AP for MIRENA (LEVONORGESTREL)